The Jackson Laboratory and colleagues create new wild-derived mice that could make it easier to draw conclusions about the effectiveness of new treatments or pharmaceuticals in humans.
The great majority of how we understand human disease, and attempt to cure it, derives from mice genetically fashioned to be prolific breeders, docile and easy to handle – all qualities that have made it the favorite tool of large-scale biomedical research. However, this human-imposed selection of these behavioral and reproductive traits has come at a hefty cost: By weeding out undesirable traits in the highly standardized laboratory mouse, researchers have also placed unseen constraints on what is possible to know and learn from them.
Beth Dumont, an evolutionary biologist at The Jackson Laboratory, and colleagues are looking to remedy this situation. By collecting mice in their natural habitats, in fields, barns and forests, and in divergent ecological niches (polar, tropical, and arid climates) across North and South America, Dumont and colleagues have developed 10 new laboratory-grade research mouse strains with genomes packed with information that had been stamped out of classical mice.
These new mouse strains, detailed recently in PLoS Genetics, will provide an important new resource for researchers worldwide: Their genomes introduce millions of novel genetic variants compared to classical inbred strains, including predicted versions of a gene that, on average, decreases the fitness of the organism carrying it, and gene-spanning structural variants, including loss of DNA, duplicated DNA, and detached chromosomes that reattach in the opposite direction – all genetic profiles that better reflect human genetic variation.
“Since the early 1900s, we’ve actively removed a lot of genetic information from laboratory mice that is incredibly relevant to human health,” said Dumont. “We’ve bred out traits that relate to anxiety, aggressiveness, and infertility, for instance, and that means we’re missing out on a wealth of potentially transformative biomedical research, making it much harder to determine how effectively new treatments or pharmaceuticals will work in humans.”
Dumont and her colleague, Professor Michael W. Nachman at the University of California, Berkeley and teams of graduate students went to work. They collected – with some difficulty – wild mice across five locations in Canada, the United States, and Brazil. These wild mice all belonged to a single mouse subspecies (M. musculus domesticus). This is important because these mice can all interbred, which is not necessarily the case with all genetically diverse mice. These mice looked very different from laboratory mice, having experienced adaptive pressures to survive and thrive in their respective environments. For example, mice from Canada were bigger and had high metabolic activity to stay warm in a colder climate; mice from Brazil were smaller and their metabolism was radically different, indicating that mice collected in Brazil were uniquely adapted to a hot climate.
Dumont, Nachman and colleagues meticulously inbred these mice for 20 generations to eliminate deleterious genes while imposing very minimal selection for docile behavior and/or reproductive output. Dumont then re-derived these mice via IVF to prevent the introduction of wild pathogens, making them now suitable for laboratory use.
That is, if you can catch them.
“They’re fast, and they don’t want you to hold them,” said Dumont. “I haven’t been bitten, but working with them does require quick reflexes.”
The wild-derived laboratory strains showed variation in phenotypic traits beyond size and speed. The introduction of millions of genetic variants captured broad variations across many biological domains. Their biochemical, neurobehavioral, physiological, morphological, and metabolic traits differed much more broadly than those in inbred laboratory mice, more accurately modeling the complex genetic basis of human disease-related phenotypes.
“Tapping into wild strains has the potential to establish a powerful suite of resources for the modeling of human traits and diseases, enabling important discoveries across pretty much every disease area,” said Dumont. “As researchers start to recognize that, we’ll see increasing interest in wild-derived lab mice.”
About The Jackson Laboratory
The Jackson Laboratory is an independent, nonprofit biomedical research institution with a National Cancer Institute-designated Cancer Center and more than 3,000 employees in locations across the United States, Japan and China. Its mission is to discover precise genomic solutions for disease and to empower the global biomedical community in the shared quest to improve human health.
Media contact: Cara McDonough, cara.mcdonough@jax.org, 919-696-3854